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ABSTRACT 
The metabolic pool of adenine nucleotides in platelets can be labeled by incubating 
platelets for 1 h  in vitro with [l'C]adenosine or [82P]orthophosphate. When these 
platelets  are  treated  with  thrombin,  the  adenine  nucleotides  released  are  not 
labeled.  Because  of this,  Holmsen's  suggestion  of a  metabolically inert  pool of 
granule  nucleotides  has  been  generally  accepted.  We  have  found  that  upon 
incubation of labeled rabbit platelets for longer times (up to 6 h) in vitro, or upon 
reinjection and  reharvesting at  times  up  to  66 h, the releasable pool of adenine 
nucleotides becomes labeled.  Because the rates of s2p and 1"C incorporation into 
this releasable pool are similar, it seems likely that these labels enter the granules 
as ATP. Equilibrium between the metabolic and granule pools is complete by 18 h. 
When rabbit platelets are labeled in vivo by intravenous injection of [s2p]ortho- 
phosphate,  peak  labeling  occurs between  60 and  70 h;  this corresponds to their 
maturation  time.  The  platelets  probably  incorporate  32p  during  their  produc- 
tion in the megakaryocytes. The specific radioactivity of the adenine nucleotides 
in  the  releasable  (granule)  pool  of these  platelets  is  the  same  as  the  specific 
radioactivity in the nonreleasable (metabolic) pool. Since inorganic phosphate in 
platelets  (and  undoubtedly  in  the  megakaryocytes)  exchanges  with  inorganic 
phosphate  in  plasma,  and  since the  radioactivity of the latter decreases rapidly, 
the  adenine  nucleotides  in  the  two  pools  must  exchange  to  maintain  the  same 
specific radioactivity. 
Transfer of adenine nucleotides into storage granules may represent a  general 
phenomenon because it has  been observed in the chromaffin cells of the adrenal 
medulla also. 
We have previously observed that, if rabbit plate- 
lets are labeled  in vivo by injection  of [32P]ortho- 
phosphate (s2Pl), platelet ATP and ADP contain 
s~p,  and  considerable  amounts  of  the  labeled 
adenine nucleotides are released from the platelets 
upon treatment with thrombin (13, 20, 25). Since 
thrombin causes the selective extrusion (release) of 
the contents of the storage granules  of platelets 
(1 !), the amine storage granules presumably con- 
tain  some  of the  labeled  nucleotides.  This  is  in 
contrast  to  the  results  obtained  with  platelets 
labeled in vitro.  A number of investigators  (8-10, 
12)  have  found that  platelets  incubated  in  vitro 
with  s2Pt, [a'C]adenosine,  or  [~'C]adenine  form 
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upon addition of collagen or thrombin. Holmsen et 
al.  (10)  showed  that  the  labeled  adenine  nucleo- 
tides are in the cytoplasm,  the mitochondria, and 
the  membranes,  and  concluded  that  only  these 
metabolic pool nucleotides become labeled during 
a  3-h incubation in vitro. They proposed  that the 
releasable adenine nucleotide pool is metabolically 
inert.  More  recently,  DaPrada  and  Pletscher  (5) 
and  Kotelba-Witkowska  et  al.  (15) have obtained 
evidence  that  there  may  be  some  transfer  or 
exchange  of  adenine  nucleotides  from  the  cyto- 
plasm  into the amine storage granules. 
We have now examined in more detail whether 
adenine  nucleotides  or  components  thereof  are 
exchanged  between  the  granule  (releasable)  and 
extragranule (nonreleasable) compartments of 
rabbit platelets by use of 82P1 or [t4C]adenosine as 
in  vitro labels and 82P1 as  an  in  vivo label for the 
adenine nucleotides. 
MATERIALS  AND  METHODS 
Nonradioactive Compounds 
The thrombin used was crude bovine thrombin (Parke, 
Davis & Co., Detroit, Mich.). p-Tosyl-L-arginine methyl 
ester  (HC1)  (TAMe)  was  obtained  from  Nutritional 
Biochemicals Corp., Cleveland, Ohio. Prostaglandin E~ 
(PGE0 was a gift from the Upjohn Company, Kalama- 
zoo,  Mich.  Pyruvate  kinase  and  phosphoenolpyruvate 
were obtained from Boehringer Mannheim GmbH, New 
York.  Luciferin-luciferase was purchased from E.I.  Du- 
pont de Nemours & Co., Wilmington, Del. 
Radioactive Compounds 
Carrier-free s2p~ in 0.02  N  HCI  was  obtained from 
New  England  Nuclear-Canada,  Ltd,  Montreal,  P.Q. 
[8-1'C]adenosine  ([~'C]adenosine),  sp  act  ~50  mCi/ 
mmol,  and  Na25tCrO,  in sterile isotonie saline, sp act 
~ 160 ￿9249  Cr, were obtained from Amersham/Searle 
Corporation, Arlington Heights, II1. 
Platelet Suspensions 
Suspensions  of  washed  platelets  from  rabbits were 
prepared  in  Tyrode's  solution  containing  albumin 
(0.35%),  after the method described by Ardlie et al. (I). 
Labeling of Platelets with 
Radioactive Cornpounds 
IN  VITgO 
[ty  Platelet  adenine nucleotides were 
labeled  by  incubating  the  platelets  suspended  in  Ty- 
rode's-albumin  solution  with  ["C]adr  (10  ￿9 
10  L~ platelets) for 60 min at 37~  After the incubation 
period the platelets were resuspended in fresh Tyrode's- 
albumin solution unless stated otherwise. 
s2el:  Platelets  were  labeied  with  [3W]  orthophos- 
phate (0.5  mCi/10 t~ platelets) in Tyrode's-albumin solu- 
tion from which unlabeled phosphate had been omitted. 
N-hydroxyethyl  pipr  sulfonic  acid 
(HEPES buffer) (5 mM) was inciuded in the suspending 
medium  to  keep the pH  at  7.35  during the incubation 
with s2P  I for 60 min at 37~  After the incubation period 
the  platelets  were  washed  once  in  modified Tyrode's- 
albumin solution containing no calcium and resuspended 
in Tyrode's-albumin solution. (Platelet count:  1.0-1.5  ￿ 
10  e tzl). 
DOUBLE LABELING:  When platelets were labeled with 
both 5tCr and [t'C]adenosine, Na~5~CrO,  (100 pCi/10 t~ 
platelets) was added to the first washing fluid. Platelets 
were incubated for 30 min at room temperature,  resus- 
pr  in  Tyrode's-albumm  solution,  incubated  with 
[t'C]adenosine, and resuspended as described above. 
IN  VIvo 
Platelets were labeled in vivo by intravenous injection 
into rabbits of 2 mCi [s~P]orthophosphate/kg, 1 mCi at 
56 h  and  1 mCi at 60 h  before the collection of blood. 
Platelet  suspensions  were  prepared  as  described.  The 
final platelet count was adjusted to  1.0  1.5  ￿  10e/#l. 
Platelet Release Reaction 
1 ml of platelet suspension ( 1.0 x  10  y platelets//zl) was 
warmed at 37~  for 5 min and then incubated with the 
control solution (0.1  ml Tyrode's) or with the thrombin 
solution (0.1  tal) for 3 min at 37"C in a  shaking device. 
The suspension was transferred rapidly to an Eppendorf 
centrifuge tube and centrifuged for  1 min at  12,000 g in 
an Eppendorf Microcentrifuge 3200 (Brinkmann Instru- 
ments, Rexdale, Ont.). The supernate was stored in an ice 
bath and analyzed for adenine nucleotides, lactate dehy- 
drogenase activity, and radioactivity. 
Repeated Thrombin Treatment 
Platelets  were  treated  three  times  with  thrombin 
(0.05  U/ml) and recovered as single platelets after each 
treatment, as dascribed elsewhere (20). 
Assays of Radioactivity 
The  amount  of  radioactivity !n  platelet  suspensions 
(for total radioactivity) or in the supernate after centrifu- 
gation was determined as described previously (13) if a 
single  label  had  been  used.  In  experiments  in  which 
platelets were labeled with ~lCr and  "C, 0.1  ml of the 
platelet suspension or the supernatant fluid was dissolved 
in  0.5  ml  NCS  solubilizer (Amersham/Searle  Corp.) 
before 10 ml of the toluene-based scintillation fluid were 
added  (5  g  2,5-diphenyloxazole  and  0.3  g  2,2- 
1-phenylenebis-[5-phenyloxazole] in  I  liter of toluene). 
s~Cr  and  "C  were  measured  simultaneously (21) in a 
Philips liquid  scintiIlation counter.  The sr  of the 
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the 61Cr was counted in the "C channel and  10% of the 
"C  in the 5tCr channei. Counts were corrected for the 
spillover. 
Adenosine  Triphosphate Assay 
For determination of the platelet ATP content, 10/~1 of 
20% Triton X-100 in ethanol was added to 1.0 ml platelet 
suspension (1.0  x  10  y platelets/tzl).  Platelet  ATP  and 
released  ATP  were  assayed  by the  luciferin-luciferase 
assay (13,  26). 
~'C-labeled  adenine  nucleotides  were  separated  by 
paper  chromatography  and  counted  by  the  methods 
described  by  Packham  et  al.  (17).  ￿87  adenine 
nucleotides  were  separated  from  each  other and  from 
inorganic "P by low voltage paper electrophoresis for 16 
h at 4~  with 0.12 M  citrate buffer, pH 4.78. 
Lactate  Dehydrogenase 
Lactate  dehydrogenase  (LDH)  was  assayed  by  the 
method of Bergmeyer et al. (4). 
Platelet Survival Studies 
Platelets  were  labeled  in  vitro  with  ~~Cr, or  ['P] 
orthophosphate as described above. Between 6 ￿  10' and 
10  ~0 platelets in 2  3 ml Tyrode's-albumin solution were 
injected  into  each  rabbit.  The  number  of  platelets 
injected corresponded to  approximately  10-15% of the 
total number of platelets in the recipient rabbit. 1, 18, 42, 
66, and 90 h after the injection of the labeled platelets, 6 
ml of blood were withdrawn from an ear vein into I ml of 
the acid-citrate-dextrose solution of Aster and Jandl (2). 
Platelets  were  prepared  from  each  sample,  washed  in 
calcium-free  Tyrode's-albumin  solution,  and  resus- 
pended in  1 ml of calcium-free Tyrode's-albumin solu- 
tion.  Platelets  were  countr  microscopicaUy,  and  the 
amount of radioactivity in 0.1  ml of the platelet suspen- 
sion  was  measured.  The  spr  radioactivity  of  the 
platelets (cpm/108 platelets) was calculated.  In experi- 
ments in which platelets were labeled with 8~p~, aliquots 
were  taken  for  electrophoretic  sr  of  the  "P- 
labeled adenine nucleotides. The results were expressed 
as counts per minute in ATP and PI per 10  ~ platelets. The 
biological half-lives of platelet  radioactive  labels were 
computed as described previously (19). 
RESULTS 
Release of [32P]A TP from  Washed 
Rabbit Platelets 
IN  VIVO  LABELING"  32P 1  injected  intrave- 
nously  (1  mCi/kg)  disappeared  rapidly  from 
the  plasma.  In  an  experiment  in  which  the  32P1 
was  given  as  a  single  injection,  90%  of  it  dis- 
appeared  from  the  plasma  between  4  min  and 
1  h  after  the  injection.  In  experiments  in  which 
the  rabbits  were  given  two  injections  of  82p1 
4  h  apart,  the  amount  of  32p  in  the  platelets 
reached  a  maximum  about 60-70 h  after the first 
injection (Fig.  1).  Rabbit platelets harvested  56 h 
after  the  second  intravenous  injection  of  s*P  t 
contained  [3zP]ATP,  [3zP]ADP,  and  [szP]AMP 
(Table  I).  After stimulation with thrombin, these 
platelets  released  32P-labeled  nucleotides  into  the 
suspending fluid. The specific radioactivity of the 
released ATP was not significantly different from 
that  of  the  platelets  before  thrombin  treatment 
(Table  II). 
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FIGUaE  1  Specific  radioactivity  of  3~p  in  platelets after  intravenous injections of "P1  at  0  and  4  h 
(0-------@).  Arrows  at  left  indicate the  times of injection. The  specific  radioactivity of the  s~p  in the 
platelet-poor plasma is also shown (121  I'-I). 
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Distribution of s2p between Adenine Nucleotides in Perchloric Acid Extracts of Platelets Labeled In Vivo or 
In Vitro with s2p~ 
Total 8,p in pr  acid extract 
Not 
ATP  ADP  AM P  P~  identified 
%  %  %  %  % 
In vivo*  44.4 •  3.6  8.1 •  0.3  3.8 •  1.3  14.8 •  1.6  28.9 
In vitro~/  45.3 4- 4.3  9.3 •  1.2  0.6 a: 0.3  38.5 •  2.2  6.4 
* Means and SEM of three experiments. 
~/Means  and SEM of five experiments. 
TABLE I I 
Specific Radioactivity of [a2P]A TP Released by Thrombin (0.5 U/ml) from  Washed Rabbit Platelets Labeled 
In Vivo with s~p~ 
[s2P]ATP  ATP  Specific activity 
In platelets before 
thrombin treatment 
In supernate after 
thrombin treatment 
cpm/ lOS platelets  nmol / lOS platelets  cpm/nmol 
896 •  62  4.8 •  0.6  194 •  10 
468 •  29  2.6 •  0.2  184 •  II 
Significance ofdifference  p <  0.3 
between means 
Means and SEM of nine experiments. Paired t test analysis.  The suspensions  contained between  30,000 and 35,000 
cpm/ml suspension.  The platelet count was  106/￿9 
IN  VITRO LABELING:  The  distribution  of  3zp 
between ATP and ADP after in vitro incubation of 
platelets with 3zpl was very similar to that after in 
vivo  labeling  with  8zP l  (Table  I).  However,  a 
much smaller percentage of the total a2p was found 
in the AMP of platelets labeled in vitro (Table I). 
In contrast  to  in  vivo labeled  platelets,  washed 
rabbit  platelets  labeled  with  s2pl  in  vitro showed 
very little release of 32P-labeled  ATP  upon  treat- 
ment  with  thrombin  (0.5  U'/ml) (Table  III).  Re- 
peated  treatment  of these platelets with thrombin 
led to a  large increase in the specific radioactivity 
of  the  [32P]ATP  remaining  within  the  platelets 
(Fig.  2).  This  is  in  contrast  to  the  much  smaller 
increase  in  specific  radioactivity  in  [3W]ATP 
found  with  the  in  vivo  labeled  platelets  upon 
thrombin  treatment  (Fig.  2). 
One explanation  for the difference between  the 
in  vitro  and  in  vivo  results  with  the  32P-labeled 
platelets  could  be that  exchange of label between 
the cytoplasm and the granules does occur hut is so 
slow that  it is not readily apparent in short-term in 
vitro studies.  This possibility was examined in the 
following experiments. 
Transfer of A den•  Nucleotide 
Components from  the Nonreleasable 
Compartment into the 
Releasable Compartment 
TRANSFER  OF  PHOSPHATE:  TO  determine 
whether  transfer  or  exchange  of  phosphate  be- 
tween  the  cytoplasmic  and  the  granule  adenine 
nucleotides  of platelets  occurs,  platelets  were  in- 
cubated  with  ~2Pl  in  vitro,  washed,  and  resus- 
pended  in  fresh  medium.  They  were  then  kept 
at  37~  and  the  percentage  of labeled  ATP that 
could be released upon  stimulation with thrombin 
(0.5  U/ml) was determined  at various times (Fig. 
3).  This figure shows that  about 9% of the labeled 
ATP in the washed  rabbit  platelets was releasable 
6  h  after  the  addition  of the  32P1 to  the  platelet 
suspension.  The  presence  of labeled  adenine  nu- 
cleotides in the supernate  of the thrombin-treated 
64  THE  JOURNAL  OF  CELL  BIOLOGY  ￿9 VOLUME  67,  1975 TABLE 11I 
Specific Radioactivity of [s2P]A Tl) Released by Thrombin (0.5 U/ml) [rom  Washed Rabbit Platelets  Labeled 
In I/itro with s2p, 
[12P]ATP  ATP  Specific  activity 
In platelets before 
thrombin treatment 
In supernate after 
thrombin treatment 
cpm/ lOS platelets  nmol/ lO" platelets  cpm/nmol 
574,000  4.2  137,000 
12,800  2.3  5,600 
* Platelet suspension  contained 7.50  ￿  10  y cpm/ml. The platelet count was  10y 
~oL y 
~~_p  20o 
<,,,~ 
￿8 
IN  VITRO  IN  VlVO 
I  I  ' 
0  I  i  i  I  i  I 
0  90  180  270  0  90  180  270 
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FIGURE 2  Specific radioactivity of [82P]ATP remaining in platelets after three treatments with thrombin 
(0.05  U/tal) (I-----------I).  On the left, platelets labeled  in vitro; on the right, platelets labeled  in vivo. Also 
shown are control values (O  O) for platelets treated three times with Tyrode's solution in the in vitro 
and in vivo experiments. Thrombin or Tyrode's solution was added  at the times indicated by the arrows. 
Specific radioactivities are expressed  as a percentage of the specific  radioactivity of the original platelet 
ATP  (counts  per  minute  per  nanomoles  ATP).  Platelet  radioactivity as  "P  at  the  beginning  of the 
experiment  was  34,732  cpm/ml of suspension  when  platelets  had  been  labeled  in  vivo,  and  1,030,000 
cpm/ml of suspension  when platelets had been labeled  in vitro (10  y platelets/#l). 
platelet suspension  could not be accounted  for by 
platelet lysis. Less than  1% of the lactate dehydro- 
genase activity (LDH) of the total platelet suspen- 
sion appeared  in the supernate at the same time as 
the adenine  nucleotides. 
To  provide  a  longer  time  for  equilibration  of 
cytoplasmic and granule phosphate, an experiment 
was done in which rabbit platelets labeled with s2P 1 
in vitro were infused into rabbits and harvested  18 
h  later.  A  suspension  of  washed  platelets  was 
prepared in the usual manner. When these platelets 
were  treated  with  thrombin  (0.05  U/ml)  they 
released 46%  of their labeled  ATP in conjunction 
with  46%  of their  total  ATP.  Thus,  the  specific 
radioactivity  of  the  released  ATP  (8,040  cpm/ 
nmol)  was  similar  to  that  of  the  unstimulated 
platelets (8,120 cpm/nmol) (means of three obser- 
vations). More than 90% of the radioactivity of the 
released  adenine  nucleotides  was  present  as 
[s2P]ATP. 
Since it  was not  possible to determine  whether 
the "P  was entering  the  releasable  pool as phos- 
phate  or  as  adenine  nucleotides,  we  examined 
whether  the  adenosine  moiety  would  cross  the 
amine storage organelle membrane as weil. 
TRANSFER OF  ADENOSINE:  When  washed  rab- 
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FIGURE 3  Percentage of thrombin-releasable s2p in the 
form  of  [a2P]ATP  after  storage  of  in  vitro  labeled 
platelets  in  Tyrode's-albumin  solution.  Platelets  were 
exposed  to a2Pl for 1 h (black bar) and then resuspended 
in  fresh  medium  containing  unlabeled  phosphate. 
Amount of releasable [a2P]ATP  was determined at 2, 3, 
4,  5,  and  6 h  by addition of 0.5  U/tal of thrombin to 
aliquots of the platelet suspension,  The platelet suspen- 
sion  contained  7.50  ￿  10' cpm/ml. The platelet count 
was  10C/pl. 
bit platelets were incubated  with 4 #M  [*'C]aden- 
nosine, it disappeared  rapidly from the suspending 
medium.  1 h  after the addition of the label to the 
platelet  suspension,  neariy  40%  of  the  "C  was 
recovered as ["C]ATP inside the platelets (Fig. 4 
a). When an aliquot of this platelet suspension was 
treated  with  thrombin  (0.5  U/ml)  1  h  after  the 
addition  of [l'C]adenosine  to the platelet suspen- 
sion,  very  little  radioactivity  was  released  as 
[t'C]ATP  (Fig.  4  b).  Aliquots  were  treated  with 
thrombin in this way at various times up to 5 h. At 
5 h, 4-5% of the radioactivity originally added was 
released  by  thrombin  as  ["C]ATP.  This  consti- 
tutes  about  9%  of  the  labeled  ["C]ATP  in  the 
platelets  before thrombin  treatment.  If the plate- 
lets  labeled  in  vitro  with  [~4C]adenosine  were 
injected into rabbits and harvested  18 h later, 52% 
+  2% (mean  and SEM  of six experiments) of the 
platelet  ["C]ATP  was  released  upon  treatment 
with thrombin (0.5  U/ml). 
The  ratio  of  ["C]ATP  to  [t'C]ADP  in  the 
released  material  was  6.4  +  0.7,  whereas  the 
["C]ATP to [~4C]ADP ratio in the platelet suspen- 
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FIGURE 4  Percentages of "C as ["C]ATP and p'C]ADP within platelets at various times after addition 
of [t4C]adenosine.  At the times indieated, aliquots of the platelr  suspension  were rr  and extracted 
with perchloric acid. The radioactive ATP and ADP in the perchloric acid extracts were separated by paper 
chromatography and counted. Results wr162  expressed  as percentages of the counts per minute added to the 
platelet suspension.  (Appropriate corrections were made for smaU amounts of [t'C]ATP and [t'C]ADP in 
the supernate of the platelet suspension.)  The suspension  contained 184,000 cpm/ml. The platr162 count was 
10'/~1. 
FIGURE 4  a  Percentages  of  radioactivity  as  [t4C]ATP  (&  &)  and  [~'C]ADP  (A  A)  in  the 
platelr 
66  THE JOURNAL OF CELL BIOLOGY ￿9 VOLUME 67,  1975 ~'~ 
301  o 
~2o 
￿9  ¦ 
<  10-  -I 
o 
n  O- 
0  60  120  180  240  300 
MINUTES 
FIGURE 4 b  Each  point represents the result of the treatment of an aliquot of the platelet suspension with 
0.5 U/ml of thrombin. The metabolic {~~C]ATP (@------~) was calculated as the difference between total 
platelet ["C]ATP (before induction of the release reaction) and the [~'C]ATP released (O  O) into the 
supernatant fluid after the addition of thrombin. 
8.9  •  0.8.  This difference was  significant (P  < 
0.025; means and S EM of seven experiments). 
In  separate  experiments  it  was  found  that  a 
similar  percentage  of  radioactive  ATP  was  re- 
leased by thrombin if platelets were isolated 18, 42, 
or 66 h  after infusion of the labeled platelets into 
rabbits (Table IV). 
To ensure that the appearance of iabeled ATP in 
the supernatant fluid upon treatment with throm- 
bin was not the result of platelet lysis rather than a 
specific release reaction, platelets were  labeled in 
some  experiments with  both  ["C]adenosine and 
5~Cr before their injection into rabbits. ~'Cr was 
used as a platelet label so that it would be possible 
to detect platelet lysis (22) if it occurred when the 
reharvested platelets were treated with thrombin. 
Table  IV  shows  that  18  h  after  the  original 
labeling,  about  50%  of  the  labeled  ATP  was 
released upon thrombin treatment. However, very 
little s~Cr appeared  in the supernate at the same 
time. Similar results were obtained if the platelets 
were  reharvested  42  h  after  the  infusion of the 
labeled platelets. However, the proportion of s~Cr 
lost from the platelets upon exposure to thrombin 
42 h after the labeling was somewhat greater than 
that after  18 h. 
Retention of [3=P]A TP and ￿87  in 
Platelets In  Vivo 
The following experiments were  done to ascer- 
tain  whether  there  is  exchange  between  platelet 
phosphate  and  plasma  phosphate,  with  corre- 
sponding changes in the specific radioactivity of 
ATP  during the  circulation of  platelets in vivo. 
When the platelets were labeled in vitro with ￿9  or 
51Cr and injected into rabbits, the total platelet 32p 
decreased  more  rapidly than  the  51Cr associated 
with the  platelets (Fig.  5).  However,  the platelet 
"=Pl disappeared  more  rapidly  than  the  platelet 
[s=P]ATP (Fig.  5).  The  rate  of disappearance of 
total  platelet  ￿9  in  all  forms  was  intermediate 
between these two rates. 
DISCUSSION 
Releasable,  i.e.  granule-bound, adenine  nucleo- 
tides do not become labeled upon in vitro incuba- 
tion of human platelets with s=P  l, [l~C]adenosine, 
or  ["C]adenine  for  a  short  period  of  time,  al- 
though  the  nonreleasable metabolic adenine nu- 
cleotides become radioactive under the same con- 
ditions (10). This has led to the conclusion that the 
granule pool does not readily incorporate adenine 
nucleotides from the metabolic pool. The adenine 
nucleotides  in  the  granules have  therefore  been 
considered as a metabolically inert pool which can 
be released upon exposure of platelets to thrombin, 
collagen, or other release-inducing agents (10).  In 
rabbit platelets, however,  DaPrada and Pletscher 
(5) were able to demonstrate a small but significant 
amount  of  newly  formed  [t'C]ATP  in  isolated 
amine storage  granules upon  exposure  of intact 
platelets to  ["C]adenosine for  2  h.  The  authors 
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Thrombin-lnduced  Release  of [l'C]A Tl) and  Loss 
ofsICr from Platelets  Labeled In Vitro and lnjected 
into Rabbits 
Experiment 
Time of  Release or Ioss 
reharvesting  (percent of total) 
of platelets 
after their  ["C] 
injection  ATP  s~Cr 
h 
18  51 
42  61  -- 
66  57  -- 
18  50  6 
42  60  13 
Experiment 1: platelets were isolated and incubated with 
["C]adenosine. The platelets were resuspended  in a fresh 
medium and injeeted into three rabbits.  At 18, 42, and 66 
h, orte of the rabbits was exsanguinated and the platelets 
were  isolated,  washed,  and  resuspended  at  a  platelet 
count of 10y249 Samples of the platelet suspension  were 
treated  with  thrombin  (0.5  U/ml) for 3  min  and  then 
eentrifuged. The supernates  were analyzed for released 
[t'C]ATP  after  chromatographic  separation.  Platelet 
suspensions  after reharvesting:  18 h, 43,060  cpm/ml; 42 
h, 8,360 cpm/ml; 66 h, 6,260 cpm/ml. 
Experiment 2: platelets were isolated and incubated with 
["C]adenosine and Na~~~CrO,. The plateiets were resus- 
pended  in  fresh  media and  injected  into rabbits.  Three 
experiments  were  done  in  which  the  platelets  were 
harvested  at  18 h  and  two in which  the platelets were 
harvested at 42 h. At these times, suspensions  of washed 
platelets were prepared  and  samples  were  treated with 
thrombin (0.5 U/ml) for 3 min and then centrifuged. The 
supernates  were  analyzed  for  5~Cr and  for  released 
[~'C]ATP  after  chromatographic  separation.  (Mean 
values  are  shown.)  Platelet  radioactivity as  ~'C  at  18 
h  was  between  25,310  and  90,700  cpm/ml of suspen- 
sion;  at 42 h it was between  10,600 and  15,470 cpm/ml 
suspension.  Platelet  radioactivity as  ~xCr at  18 hr was 
between  13,050 and  56,560  cpm/ml  of suspension;  at 
42  h  it was  between  8,080,and  19,250 cpm/ml of sus- 
pension. 
concluded that  some of the triphosphonucleotides 
formed in the metabolic pool could be transferred 
into the storage organelles. 
The  results  of the present experiments  indicate 
that  prolonged incubation  in vitro of rabbit plate- 
lets that have been labeled in vitro with either 32P1 
or  [14C]adenosine  results  in  the  gradual  appear- 
ance of labeled ATP that can be released from the 
platelets  when  they  are  exposed  to  thrombin. 
Similar  observations  were  made  when  platelets 
were  labeled  with  these  substances  in  vitro,  rein- 
fused into rabbits  and  reharvested  after a  number 
of hours.  There  are  two  possible  sources  of this 
labeled  nucleotide:  the  cytoplasm  and  the  amine 
storage  organelles.  Released  material  could  not 
have  come  from  the  cytoplasm  because  the  per- 
centages  of  6~Cr  or  of  lactate  dehydrogenase 
activity which  were lost from  the cytoplasm were 
rauch less than the percentage of labeled ATP lost. 
In  addition,  shortly  after  labeling  in  vitro,  when 
almost all of the label is in the metabolically active 
pool (10),  addition  of thrombin did not cause any 
release of labeled ATP. Thus, the storage granules 
must be the source of the radioactive ATP released 
from  the  platelets  after  prolonged  incubation  in 
vitro,  or  from  platelets  that  had  been  reinjected 
and  reharvested  after  18-66 h. 
Since both labels used in our study (32p and x~C) 
appeared  in the releasable pool at a  similar rate it 
seems  likely  that  labeled  ATP  formed  in  the 
metabolic pool of the platelets was transferred  as 
an intact molecule into the granule pool.  It seems 
likely that ATP or its breakdown products can also 
be transferred  from the granules to the cytoplasm 
since equilibration of the cytoplasmic and granule 
pool  ATP  appeared  to  be  complete  by  18  h; 
platelets  harvested  18,  42,  or  66  hours  after  the 
infusion  into rabbits  released practically the same 
percentage  of radioactive ATP at  all these times, 
upon addition of thrombin. 
Further  studies  were  done  to  investigate  the 
transfer  of labeled  ATP  or  its products  from  the 
granules  to  the  cytoplasm.  After the  injection  of 
a2pj  into  rabbits,  labeled  inorganic  phosphate  is 
not  incorporated  rapidly  into  platelet  adenine 
nucleotides  because  the  labeling  of  the  01atelets 
is  low  when  the  plasma  level  of  32p  is  highest. 
Peak  labeling  of  the  platelets  does  not  occur 
until  2-3  days  after the injection of 82pj  and  ap- 
pears  to  coincide  with  the  known  maturation 
time  for  rabbit  platelets  as  derived  from  studies 
in  which  [3~S]sulfate  (7)  or  [75Se]selenomethio- 
nine  was  used  (6).  Thus,  it  appears  reasonable 
to  conclude  that  the majority  of the  82p  labeling 
of the platelets in the in vivo experiments occurred 
at  some  stage  during  the  maturation  of platelets 
in  the  megakaryocytes.  Presumably,  at  some 
point  during  this  process,  both  the  cytoplasmic 
and  granule nucleotides incorporate labeled phos- 
phate  by  de  novo  synthesis.  It  seems  likely that 
during  the  maturation  of  the  platelets  the  spe- 
cific  radioactivity  of  the  ATP  in  the  cytoplas- 
mic  pool  and  the  granule  pool  is  the  same.  We 
found that the specific radioactivity of the ATP in 
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FIGUItE 5  Platelet  radioactivity after  in  vitro  labeling  with  5~Cr (O-~r-I)  or  ￿87  Total  platr 
radioactivity as ~~P (O-------~), platelet radioactivity as inorganic phosphate ~2p~ (A  A), and platr 
radioactivity as ["P]ATP (V  y) (means •  SEM of r  experimente). Labelr  platelr  wr162  in- 
jeeted into rabbits, and blood samplr  were takr  at the times indieatr  Platelets werr isolatr  and 
labelr  compounds were separated and countr  Speeific radioactivities (epm/10' platr162  arr  plottr 
as a pr  of the initial spr  radioactivity of the correeponding J2P-labeled material. The half- 
life for the disappearanee of platelet-bound 5  ~Cr from the circula~ion  was 24.9 •  2.0 h. 
both pools was also the same 60 h after injection of 
aaPt. If the ATP in the granule pool could not be 
transferred  to  the  cytoplasm,  one  would  expect 
that  the  specific radioactivity of the ATP in the 
two pools would differ at 60 h because the specific 
radioactivity of the  plasma  phosphate  falls  and 
there is an exchange of phosphate between plate- 
lets and plasma. (This is demonstrated by the fact 
that when 32P-labeled platelets were reinjected into 
rabbits, the specific radioactivity of platelet-bound 
32p decreased more rapidly than that of platelet- 
bound ~lCr,  and by Holmsen's [81 demonstration 
that rabbit platelets in plasma take up 3~P-labeled 
inorganic phosphate,) However, 60 h after intrave- 
nous injection of s~p (at a time when the specific 
radioactivity of the  plasma  phosphorus  was  less 
than that of the platelet phosphorus), the ATP in 
the metabolic pool and the ATP in the releasable 
pool  had  the  same  specific  radioactivity.  1 
Therefore  it  seems  likely  that  the  ATP  (or  its 
metabolites) in the granules can be transferred to 
~The small increase in the  specific radioactivity after 
repeated thrombin-induced release reactions nnay be due 
to sonne  preferential lose of an older (lese labeled) platelet 
population. During repeated thrombin-induced aggrega- 
tion, about 30% of the platelr  arr lost compared to 10% 
loss in the control suspr  (20). 
the cytoplasm. Thus, ATP appears to exchange in 
both directions across the granule membrane. 
From the results of the present experiments the 
absolute amount of ATP transported per unit time 
from the  metabolic pool into the  releasable pool 
can be estimated. From Table II it can be calcu- 
lated that the metabolic pool contains 2.2 nmol of 
ATP per  108 platelets; from Fig. 3 and Fig. 4 it is 
apparent  that  about  2%  of  the  labeled  adenine 
nucleotides in the  metabolic pool are transferred 
into  the  granules  per  hour.  Thus,  the  rate  of 
transfer of ATP can be calculated to be approxi- 
mately  44  pmol/10  s  platelets/h.  This  may  be 
compared  to  the  maximum  rate  of  serotonin 
transfer from  the cytoplasm into the granules of 
17.2  nmol/10  s  platelets/h  that  was  observed  in 
experiments reported previously (18).  Since sero- 
tonin is transferred into the granules at a rate that 
is  at  least  300  times  greater  than  the  rate  of 
transfer of ATP, it seems unlikely that transfer of 
serotonin  into  the  granules  is  linked  to  ATP 
transport. 
Cells other than platelets also possess granules 
which eontain adenine nucleotides (16). Stevens et 
al. (23) demonstrated that radioactive adenosine is 
taken  up  by  the  isolated  perfused  ent  adrenat 
gland, and that  radioactive ATP accumulates in 
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leased  upon stimulation with carbachol. This may 
indicate  that  labeled  nucleotides  formed  in  the 
metabolic  pool  of  these  cells  can  be  transferred 
into the  chromaffin granules.  Nucleotide transfer 
from the metabolic pool into the storage granules 
of cells  may  thus  be a  phenomenon  which  is not 
limited  to  platelets.  There  is  other  evidence  for 
translocation  of adenine nucleotides across  mem- 
branes. Among the best known is the transport of 
adenine  nucleotides  across  the  mitochondrial 
membrane  via  a  specialized  carrier  system  (14). 
Adenine nucleotides can also diffuse across artifi- 
cial bimolecular lipid membranes, a process that is 
stimulated by divalent metal cations (24). Further- 
more,  isolated  chromaffin granules  have recently 
been shown to take up small amounts of radioac- 
tive ATP (3). 
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